Biobanking Market Research Report By Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User - Global Forecast to 2034
May-2025 Formats | PDF | Category: Healthcare | Delivery: 24 to 72 Hours
“The Biobanking Market industry is expected to expand from $3.4 Billion in 2025 to $ 7.6 Billion in 2034, with a compound annual growth rate of 11.6% “
Biobanking Market: Overview and Growth in the Upcoming Year
In the quickly changing domains of research and medicine, biobanks are crucial for organising and storing biological samples for later use. The biobanking industry has grown dramatically over the last few years, and analysts predict even more significant growth in the upcoming year. This article will provide an overview of the biobanking market, emphasising the key trends and factors propelling its growth.
A biobank is a facility that stores biological samples, such as blood, tissue, and DNA, for use in clinical trials, medical research, and other scientific studies. These samples are collected from individuals with their consent and stored in specific conditions to maintain their quality and integrity.
There are several reasons why the biobanking market is growing. One significant driver is the increasing demand for personalised medicine, which tailors treatments for individual patients based on genetic and molecular information. Biobanks are crucial to this process because they provide scientists and medical professionals with access to a wide variety of biological samples for analysis.
Another factor driving the growth of the biobanking market is the rising prevalence of chronic diseases like diabetes and cancer. Larger collections of biological samples are required for research and development because these diseases are becoming more prevalent as the world’s population ages and lifestyles change.
One of the latest innovations in the biobanking sector is the application of advanced technology, such as automation and robots, to improve sample processing and storage. These technologies not only increase efficiency and accuracy but also enable the storage of a greater range of sample types, including microbiome and liquid biopsy samples.
Another trend is the increased focus on data management in biobanks and bioinformatics. Biobanks are making investments in methods to effectively arrange and examine the growing volume of biological samples. This development is driving the need for bioinformatics and data science specialists to work in biobanking facilities.
For Insights Consultancy’s latest market intelligence study, “Global Biobanking Market 2025, Growth Opportunities, and Forecast,” provides a comprehensive analysis of the Food industry. The report includes demand analysis, industry insights, competition intelligence, and a customer database. It also offers strategic insights into future trends, growth determinants, supplier landscape, demand landscape, CAGR, and pricing analysis. The study also includes Porter’s Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps’ Analysis, Market Attractiveness Analysis, BPS Analysis, and Ecosystem Analysis.
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 110+ is available for purchase to all the interested stakeholders.
Top Companies Covered In This Report:
- Thermo Fisher Scientific
- PHC Holdings Corporation (Japan)
- Becton
- Dickinson and Company (US)
- QIAGEN N.V. (Germany)
- Merck KGaA (Germany)
- Avantor Inc. (US)
- Cryoport
- Tecan Trading AG (Switzerland)
- Azenta
- Greiner Holding AG (Austria)
- Hamilton Company (US)
- Micronic (Netherlands)
- AMSBIO (UK)
- Bay Biosciences LLC (US)
- BioKryo (Germany)
- SPT Labtech (UK)
- ASKION GmbH (Germany)
- Cell&Co BioServices (France)
- Ziath Ltd. (UK)
- CTIBiotech (France)
- Cureline (US)
- Firalis Group (France)
- Sopachem (Netherlands)
- ProteoGenex (US)
- US Biolab Corporation
Industry News
17 Dec 2024, Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids. The company is based in Utrecht, Netherlands and employs around 70 people. Terms of the deal were not disclosed. The transaction is expected to close at the end of December 2024.
28 NOV 2024, Thermo Fisher Scientific Announces HUNT Biobanks Selection of Thermo Scientific Nautilus LIMS for One of the Largest Population-Based Health Studies.
Thermo Fisher Scientific Inc., the world leader in serving science, announces that HUNT Biobank has selected its Thermo Scientific Nautilus LIMS to gather, store, manage, track and retrieve the biological data of approximately 100,000 people from Nord-Trndelag County, Norway, as part of one of the largest population-based health studies ever performed.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2034, Y-o-Y growth rate, and CAGR):
Segment By Product &Service
- Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
- Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
- Services
- Storage Services
- Processing Services
- Transport Services
- Supply Services
- Software
Segment By Sample Type
- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acids
- Biological Fluids
- Human Waste Products
By Storage Type
- Manual Storage
- Automated Storage
By Ownership
- Universities
- National/Regional Agencies
- Non-Profit Organizations
- Private Organizations
By Application
- Regenerative Medicine
- Life Science Research
- Clinical Research
By End user
- Pharmaceutical & Biotechnology Companies and CROs
- Academic & Research Institutes
- Hospitals
Regional Deep-dive Analysis:
The report provides in-depth qualitative and quantitative data on the Biobanking Market for all of the regions and countries listed below:
North America includes the United States, Canada, and Mexico.
Europe includes Germany, France, Italy, the United Kingdom, Scandinavia, Benelux, Russia, and the rest of Europe.
Asia-Pacific includes Japan, South Korea, India, China, Southeast Asia, and Australia.
South America (including Brazil, Argentina, and the rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Israel, South Africa)
Each country is studied in detail, and the study includes qualitative and quantitative analysis of the Biobanking Market in that country.
North America
Government programmes, technological advancements, and a sizable number of biotechnology and pharmaceutical companies are all contributing to the growth of the biobanking sector in North America. The US is setting the standard for biobanking activities thanks to its robust infrastructure and growing number of biobanks meeting various research needs. Canada is also emerging as a significant player in the biobanking market as a result of several research institutes investing in biobanking facilities. Generally speaking, North America accounts for a sizable share of the global biobanking market.
Europe
With countries like Germany, the UK, and France setting the standard for biobank operations and infrastructure, Europe is another important region in the biobanking industry. The connections between research teams, academic institutions, and biopharmaceutical companies define the European biobanking industry. With a strong focus on data protection and regulatory compliance, Europe offers a favourable environment for biobanking operations. The biobanking market is expected to grow gradually across the continent in the years to come.
Asia-Pacific
The Asia Pacific region’s biobanking footprint is expanding rapidly due to an increased emphasis on precision medicine and genomics research. Countries such as China, Japan, and India are investing heavily in biobanking infrastructure to support their growing healthcare industries. The region has a lot of potential for biobanking companies because of its large population and growing healthcare costs. As long as it continues to make progress, Asia Pacific is poised to become a major player in the global biobanking market.
Middle East and Africa
Middle East’s biobanking sector is still in its early stages, despite efforts by countries like the United Arab Emirates, Saudi Arabia, and Qatar to establish biobanks for medical research and treatment. The region’s unique genetic diversity and the prevalence of particular diseases make it an ideal site for biobanking operations. Given that Middle Eastern governments place a high value on healthcare innovation and research, the biobanking sector is expected to grow significantly in the near future.
The research provides answers to the following key questions:
- What is the expected growth rate of the Biobanking Market from 2025-2034?
- What are the key driving forces shaping the market during the forecast period?
- Who are the major market vendors and what winning strategies have helped them occupy a strong foothold in the Biobanking Market?
- What are the prominent market trends influencing the market’s development?
Key insights provided by the report that could help you take critical strategic decisions?
- Regional reports analyse product/service consumption and market factors in each region.
- Reports highlight possibilities and dangers for suppliers in the Biobanking Market business globally.
- The report identifies regions and sectors with the highest growth potential.
- It provides a competitive market ranking of major companies, as well as information on new product launches, partnerships, business expansions, and acquisitions.
- The report includes a comprehensive corporate profile with company overviews, insights, product benchmarks, and SWOT analysis for key market participants.
Customization: We can provide following things
1) On request more company profiles (competitors)
2) Data about particular country or region
3) We will incorporate the same with no additional cost (Post conducting feasibility).
Any Requirement Contact us: https://www.forinsightsconsultancy.com/contact-us/
Table of Contents
For TOC Contact us: https://www.forinsightsconsultancy.com/contact-us/
